These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution. Hornick JL; Fletcher CD Am J Clin Pathol; 2002 Feb; 117(2):188-93. PubMed ID: 11865845 [TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma. Jagdis A; Rubin BP; Tubbs RR; Pacheco M; Nielsen TO Am J Surg Pathol; 2009 Dec; 33(12):1743-51. PubMed ID: 19809272 [TBL] [Abstract][Full Text] [Related]
4. PKC-theta expression in Ewing sarcoma/primitive neuroectodermal tumour and malignant peripheral nerve sheath tumour. Kang GH; Kim KM; Park CK; Kang DY Histopathology; 2009 Sep; 55(3):368-9. PubMed ID: 19723158 [No Abstract] [Full Text] [Related]
5. TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies. Terry J; Saito T; Subramanian S; Ruttan C; Antonescu CR; Goldblum JR; Downs-Kelly E; Corless CL; Rubin BP; van de Rijn M; Ladanyi M; Nielsen TO Am J Surg Pathol; 2007 Feb; 31(2):240-6. PubMed ID: 17255769 [TBL] [Abstract][Full Text] [Related]
6. TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): analysis of 319 cases. Knösel T; Heretsch S; Altendorf-Hofmann A; Richter P; Katenkamp K; Katenkamp D; Berndt A; Petersen I Eur J Cancer; 2010 Apr; 46(6):1170-6. PubMed ID: 20189377 [TBL] [Abstract][Full Text] [Related]
7. Poorly differentiated synovial sarcoma: immunohistochemical distinction from primitive neuroectodermal tumors and high-grade malignant peripheral nerve sheath tumors. Folpe AL; Schmidt RA; Chapman D; Gown AM Am J Surg Pathol; 1998 Jun; 22(6):673-82. PubMed ID: 9630174 [TBL] [Abstract][Full Text] [Related]
8. Specificity of TLE1 expression in unclassified high-grade sarcomas for the diagnosis of synovial sarcoma. Valente AL; Tull J; Zhang S Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):408-13. PubMed ID: 23197007 [TBL] [Abstract][Full Text] [Related]
9. A reappraisal of hemangiopericytoma of bone; analysis of cases reclassified as synovial sarcoma and solitary fibrous tumor of bone. Verbeke SL; Fletcher CD; Alberghini M; Daugaard S; Flanagan AM; Parratt T; Kroon HM; Hogendoorn PC; Bovée JV Am J Surg Pathol; 2010 Jun; 34(6):777-83. PubMed ID: 20421780 [TBL] [Abstract][Full Text] [Related]
10. Frequency of Transducer-like Enhancer of Split 1 Immunohistochemical Expression in Synovial Sarcoma: An Institution-based Cross-sectional Study. Qureshi MB; Uddin N; Tariq MU; Raheem A; Pervez S Cureus; 2019 Dec; 11(12):e6357. PubMed ID: 31938642 [TBL] [Abstract][Full Text] [Related]
11. TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasms. Kosemehmetoglu K; Vrana JA; Folpe AL Mod Pathol; 2009 Jul; 22(7):872-8. PubMed ID: 19363472 [TBL] [Abstract][Full Text] [Related]
12. Transducer-like Enhancer of Split 1 as a Novel Immuno- histochemical Marker for Diagnosis of Synovial Sarcoma. Atef A; Alrashidy M Asian Pac J Cancer Prev; 2015; 16(15):6545-8. PubMed ID: 26434872 [TBL] [Abstract][Full Text] [Related]
13. Utility of characteristic 'Weak to Absent' INI1/SMARCB1/BAF47 expression in diagnosis of synovial sarcomas. Rekhi B; Vogel U APMIS; 2015 Jul; 123(7):618-28. PubMed ID: 25912315 [TBL] [Abstract][Full Text] [Related]
14. Cluster analysis of immunohistochemical profiles in synovial sarcoma, malignant peripheral nerve sheath tumor, and Ewing sarcoma. Olsen SH; Thomas DG; Lucas DR Mod Pathol; 2006 May; 19(5):659-68. PubMed ID: 16528378 [TBL] [Abstract][Full Text] [Related]
16. Transducer-like enhancer of split 1 (TLE1) as a novel biomarker for diagnosis of synovial sarcoma correlates with translocation t(X;18): a study of 155 cases in China. Li Y; Zhang X; Wang A; Ding S; Li Y; Wang H; Lv Y; Shi H Int J Clin Exp Pathol; 2019; 12(1):251-258. PubMed ID: 31933740 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical validation of TLE1, a novel marker, for synovial sarcomas. Rekhi B; Basak R; Desai SB; Jambhekar NA Indian J Med Res; 2012 Nov; 136(5):766-75. PubMed ID: 23287123 [TBL] [Abstract][Full Text] [Related]
18. Low-affinity nerve growth factor receptor (p75) in dermatofibrosarcoma protuberans and other nonneural tumors: a study of 1,150 tumors and fetal and adult normal tissues. Fanburg-Smith JC; Miettinen M Hum Pathol; 2001 Sep; 32(9):976-83. PubMed ID: 11567228 [TBL] [Abstract][Full Text] [Related]
19. Malignant peripheral nerve sheath tumors with t(X;18). A pathologic and molecular genetic study. O'Sullivan MJ; Kyriakos M; Zhu X; Wick MR; Swanson PE; Dehner LP; Humphrey PA; Pfeifer JD Mod Pathol; 2000 Dec; 13(12):1336-46. PubMed ID: 11144931 [TBL] [Abstract][Full Text] [Related]